Industry
Biotechnology
Topic
Investments
People
Find news about people
Organizations
Find news about organizations
Alumni
Find news on alumni of any org
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Investments in Biotechnology
... Ncardia, an emerging drug discovery and development stem cell technology company whose mission ...
... Torque, an immuno-oncology company developing Deep Primed(TM) cell therapies that direct and evoke ...
... to list on the NYSE as "BXG." [ts_bullet_primary] Fireman B.V . or InflaRx , a Jena, Germany,-based pharmaceutical company developing treatments for inflammatory diseases, raised ...
... such newly created vacancy. Mr. Nussbaum was a founding Board Member of Kite Pharma and holds other Board positions at Pontifax portfolio companies. "We are ...
... Kezar Life Sciences, a private, clinical-stage biopharmaceutical company developing novel small molecule therapeutics, today ...
... to develop and manufacture surgical implants for its United States-based surgical partner, TELA Bio. Brian Ward, chief executive of Aroa Biosurgery, says TELA Bio's OviTex(TM) ...
... company plans to list on the NYSE. [ts_bullet_primary] Fireman B.V . or InflaRx , a Jena, Germany,-based pharmaceutical company developing treatments for inflammatory diseases, said ...
... Prenetics, a Southeast Asia-based genetics-focused digital health company, has raised $40 million in ...
... app with much less risk and cost. The companys core technology, Pensa Maestro, is a cloud-based system that enables enterprises to rapidly create multi-vendor, multi-platform ...
... red liquid may be an unsettling sight. But for Canadian-backed biotech Novoheart Holdings Inc., these miniature lab-grown hearts may represent the future of drug testing ...
... MPM Managing Director. World Class Management CEO Owen Hughes joined Cullinan from Intarcia Therapeutics, where he served as the Chief Business Officer and Head of ...
... made a EUR 15 m investment to take a minority stake in Exscientia. Through this investment, Evotec becomes the first strategic shareholder in the UK-based ...
... deal. The company plans to list on the Nasdaq as "MBIN." [ts_bullet_primary] Rhythm Pharmaceuticals, a biotech developing obesity treatments, says it plans to raise $100 ...
Want to see the full history of news or view news on a particular date? Upgrade to RelSci Professional now!
Start My Free Trial ➤